The present study firstly shows the anti-tumor potential of fluvastatin in endometrial cancer and reveals the role of SIRT6 in the mechanism of action of fluvastatin, providing a novel sight for the therapy of endometrial cancer and the study of mechanism of endometrial cancer. This evidence concerns the gene SIRT6 and neoplasm.